143 related articles for article (PubMed ID: 1349007)
21. Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors.
Melhem MF; Meisler AI; Finley GG; Bryce WH; Jones MO; Tribby II; Pipas JM; Koski RA
Cancer Res; 1992 Nov; 52(21):5853-64. PubMed ID: 1394214
[TBL] [Abstract][Full Text] [Related]
22. Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinoma.
Bollito E; Berruti A; Bellina M; Mosca A; Leonardo E; Tarabuzzi R; Cappia S; Ari MM; Tampellini M; Fontana D; Gubetta L; Angeli A; Dogliotti L
Ann Oncol; 2001; 12 Suppl 2():S159-64. PubMed ID: 11762345
[TBL] [Abstract][Full Text] [Related]
23. Neuroendocrine differentiation in gastric adenocarcinomas associated with severe hypergastrinemia and/or pernicious anemia.
Qvigstad G; Qvigstad T; Westre B; Sandvik AK; Brenna E; Waldum HL
APMIS; 2002 Feb; 110(2):132-9. PubMed ID: 12064868
[TBL] [Abstract][Full Text] [Related]
24. Different patterns of chromogranin A and Leu-7 (CD57) expression in gastrointestinal carcinoids: immunohistochemical and confocal laser scanning microscopy study.
Jirásek T; Hozák P; Mandys V
Neoplasma; 2003; 50(1):1-7. PubMed ID: 12687271
[TBL] [Abstract][Full Text] [Related]
25. Metastatic conventional prostatic adenocarcinoma with diffuse chromogranin A and androgen receptor positivity.
Roudier MP; True LD; Vessella RL; Higano CS
J Clin Pathol; 2004 Mar; 57(3):321-3. PubMed ID: 14990610
[TBL] [Abstract][Full Text] [Related]
26. In situ hybridization analysis of chromogranin A and B mRNAs in neuroendocrine tumors with digoxigenin-labeled oligonucleotide probe cocktails.
Lloyd RV; Jin L
Diagn Mol Pathol; 1995 Jun; 4(2):143-51. PubMed ID: 7551295
[TBL] [Abstract][Full Text] [Related]
27. Somatostatin type 2A receptor immunoreactivity in human pancreatic adenocarcinomas.
Pilichowska M; Kimura N; Schindler M; Kobari M
Endocr Pathol; 2001; 12(2):147-55. PubMed ID: 11579680
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of elevated serum chromogranin A levels.
Syversen U; Ramstad H; Gamme K; Qvigstad G; Falkmer S; Waldum HL
Scand J Gastroenterol; 2004 Oct; 39(10):969-73. PubMed ID: 15513336
[TBL] [Abstract][Full Text] [Related]
29. Chromogranin A-positive tumor cells in human esophageal squamous cell carcinomas.
Yuan A; Liu J; Liu Y; Cui G
Pathol Oncol Res; 2007; 13(4):321-5. PubMed ID: 18158567
[TBL] [Abstract][Full Text] [Related]
30. Neuroendocrine differentiation in carcinoma of the breast. Tyramide signal amplification discloses chromogranin A-positive tumour cells in more breast tumours than previously realized.
Bofin AM; Qvigstad G; Waldum C; Waldum HL
APMIS; 2002 Sep; 110(9):658-64. PubMed ID: 12529020
[TBL] [Abstract][Full Text] [Related]
31. Expression of the gastrin gene in the normal human colon and colorectal adenocarcinoma.
Finley GG; Koski RA; Melhem MF; Pipas JM; Meisler AI
Cancer Res; 1993 Jun; 53(12):2919-26. PubMed ID: 8504433
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical and ultrastructural features of neuroendocrine differentiated carcinomas of the prostate: an immunoelectron microscopic study.
Hirano D; Jike T; Okada Y; Minei S; Sugimoto S; Yamaguchi K; Yoshikawa T; Hachiya T; Yoshida T; Takimoto Y
Ultrastruct Pathol; 2005; 29(5):367-75. PubMed ID: 16257863
[TBL] [Abstract][Full Text] [Related]
33. Expression of pS2 in prostate cancer correlates with grade and Chromogranin A expression but not with stage.
Ather MH; Abbas F; Faruqui N; Israr M; Pervez S
BMC Urol; 2004 Dec; 4(1):14. PubMed ID: 15588310
[TBL] [Abstract][Full Text] [Related]
34. Neuroendocrine cells in diffuse gastric carcinomas: an ultrastructural study with immunogold labeling of chromogranin A.
Martinsen TC; Skogaker NE; Fossmark R; Nordrum IS; Sandvik AK; Bendheim MØ; Bakkelund KE; Waldum HL
Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):62-8. PubMed ID: 19713831
[TBL] [Abstract][Full Text] [Related]
35. CDX1 protein expression in normal, metaplastic, and neoplastic human alimentary tract epithelium.
Silberg DG; Furth EE; Taylor JK; Schuck T; Chiou T; Traber PG
Gastroenterology; 1997 Aug; 113(2):478-86. PubMed ID: 9247467
[TBL] [Abstract][Full Text] [Related]
36. Sinonasal intestinal-type adenocarcinoma: immunohistochemical profile and comparison with colonic adenocarcinoma.
McKinney CD; Mills SE; Franquemont DW
Mod Pathol; 1995 May; 8(4):421-6. PubMed ID: 7567943
[TBL] [Abstract][Full Text] [Related]
37. Neuroendocrine in Barrett's mucosa and adenocarcinomas of the gastroesophageal junction.
Koppert LB; Wijnhoven BP; Tilanus HW; Stijnen T; Van Dekken H; Dinjens WN
Int J Surg Pathol; 2004 Apr; 12(2):117-25. PubMed ID: 15173916
[TBL] [Abstract][Full Text] [Related]
38. Characterization of scattered neuroendocrine cells in ductal carcinoma of the pancreas.
Tezel E; Nagasaka T; Tezel G; Nakao A
Pancreas; 2002 Aug; 25(2):136-41. PubMed ID: 12142735
[TBL] [Abstract][Full Text] [Related]
39. Chromogranin A and B and secretogranin II in prostatic adenocarcinomas: neuroendocrine expression in patients untreated and treated with androgen deprivation therapy.
Pruneri G; Galli S; Rossi RS; Roncalli M; Coggi G; Ferrari A; Simonato A; Siccardi AG; Carboni N; Buffa R
Prostate; 1998 Feb; 34(2):113-20. PubMed ID: 9465942
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of S100A6 (Calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas.
Komatsu K; Andoh A; Ishiguro S; Suzuki N; Hunai H; Kobune-Fujiwara Y; Kameyama M; Miyoshi J; Akedo H; Nakamura H
Clin Cancer Res; 2000 Jan; 6(1):172-7. PubMed ID: 10656447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
